PCSK9 pipeline

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 12期
关键词：
D O I：
10.1038/nrd.2016.258
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [1] PCSK9 pipeline
    Asher Mullard
    Nature Reviews Drug Discovery, 2016, 15 : 811 - 811
  • [2] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [3] PCSK9
    Abifadel, M.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [5] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [6] PCSK9 inhibitors
    Farnier, Michel
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
  • [7] The mystery of PCSK9
    Attie, AD
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) : 1337 - 1339
  • [8] PCSK9 IN YOUTH
    Baass, A.
    Dubuc, G.
    Lambert, M.
    Davignon, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] The PCSK9 decade
    Lambert, Gilles
    Sjouke, Barbara
    Choque, Benjamin
    Kastelein, John J. P.
    Hovingh, G. Kees
    JOURNAL OF LIPID RESEARCH, 2012, 53 (12) : 2515 - 2524
  • [10] The PCSK9 story
    Abifadel, Marianne
    Boileau, Catherine
    EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1341 - 1342
12345